proxyvotesnow.com

Home › Companies › NeoGenomics, Inc. › 2025-2026

NeoGenomics, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and NeoGenomics, Inc.’s Form 8-K, filed 2026-05-22 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 15Reported items
  • 288Asset managers
  • 3,488Fund votes
  • 2026-05-21Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore NeoGenomics, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by NeoGenomics, Inc.

These tallies are NeoGenomics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-22 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

NeoGenomics, Inc. — official shareholder meeting results, meeting held 2026-05-21
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Lynn A. Tetrault 105,727,8633,367,9121,276,412 --6,257,933 Majority: yes
Elect Director: Dr. Marjorie C. Green 109,519,041778,68274,464 --6,257,933 Majority: yes
Elect Director: Dr. Neil Gunn 107,351,5922,945,14075,455 --6,257,933 Majority: yes
Elect Director: Stephen M. Kanovsky 109,295,532973,974102,681 --6,257,933 Majority: yes
Elect Director: Michael A. Kelly 104,709,2385,604,89158,058 --6,257,933 Majority: yes
Elect Director: John P. Kenny 110,028,235268,74875,204 --6,257,933 Majority: yes
Elect Director: David B. Perez 106,880,5333,425,13666,518 --6,257,933 Majority: yes
Elect Director: Felicia Williams 109,486,148792,26393,776 --6,257,933 Majority: yes
Elect Director: Anthony P. Zook 109,656,654657,83657,697 --6,257,933 Majority: yes
Proposal 2: The approval, on an advisory basis, of the compensation paid to the Company's Named Executive Officers, as identified in the proxy statement for the Annual Meeting. The advisory approval received an affirmative vote of a majority of the votes cast 91,781,83318,534,23656,118 --6,257,933 Majority: yes
Proposal 3: The approval of the Amendment, as identified in the proxy statement for the Annual Meeting. The stockholders approved the proposal by the following vote: 108,010,4932,308,92252,772 --6,257,933 Majority: yes
Proposal 4: The ratification of the appointment of Deloitte & Touche LLP as the independent registered public accountant. The stockholders approved the proposal by the following vote: 116,103,093494,86932,158 ---- Majority: yes

Source: NeoGenomics, Inc., Form 8-K, filed with the SEC on 2026-05-22 — read the filing on EDGAR.

How asset managers voted at the NeoGenomics, Inc. 2025-2026 meeting

Each item below shows how the 288 asset managers that disclosed a NeoGenomics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of NeoGenomics, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2026-05-21.

Combines 13 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%AGAINST 17%
FOR: 91,781,833AGAINST: 18,534,236

NeoGenomics, Inc.’s own tally for this item (“Proposal 2: The approval, on an advisory basis, of the compensation paid to the Company's Named Executive Officers, as identified in the proxy statement for the Annual Meeting. The advisory approval received an affirmati”): 91,781,833 for, 18,534,236 against, per its Form 8-K filed 2026-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 129,653,642 outstanding shares: 71% for, 14% against (85% of the company cast a for/against vote).

The 284 asset managers below cast 86% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 85%14%
FOR: 84.6%AGAINST: 13.7%ABSTAIN: 0.0%SPLIT: 1.6%NOT VOTED: 0.0%
Largest asset managers voting on “Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers.” at NeoGenomics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock16,073,25542,234 00For
Vanguard14,584,41719,901 00For
First Light Asset Management, LLC9,091,9790 00For
Greenhouse Funds LLLP7,480,1930 00For
First Trust6,219,1340 00For
State Street4,600,3016,563 00For
GEODE CAPITAL MANAGEMENT, LLC3,218,8280 00For
Fidelity3,193,6370 00For
NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST3,167,7780 00For
Aberdeen03,148,935 00Against
Loomis Sayles154,7212,843,620 00Against
Delaware/Macquarie2,787,2050 00For
SAMLYN CAPITAL, LLC2,563,7780 00For
Charles Schwab2,271,7500 00For
DE Shaw2,051,1870 00For
GW&K Investment Management, LLC037,872 00Split
PFM Health Sciences, LP1,542,5660 00For
Northern Trust1,516,07911,172 00For
DRIEHAUS CAPITAL MANAGEMENT LLC1,441,9780 00For
BANK OF AMERICA NA01,269,267 00Against
Dimensional0993,997 00Against
FRED ALGER MANAGEMENT, LLC0858,753 00Against
BRAIDWELL LP808,1440 00For
ALGER FUNDS0801,150 00Against
SEGALL BRYANT & HAMILL, LLC796,1430 00For

Showing the 25 largest of 284 asset managers. See all 284 in the interactive database.

2. Approval of the Second Amendment of the NeoGenomics, Inc. 2023 Equity Incentive Plan.

COMPENSATION

Meeting held 2026-05-21.

Combines 3 wordings of this item as funds reported it.

99.2% fund support · no official result

FOR 99.2%

The 77 asset managers below cast 99.2% of the shares they voted on this item FOR (59,661,914 for, 472,628 against).

FOR: 59,661,914 (99.2%)AGAINST: 472,628 (0.8%)
Largest asset managers voting on “Approval of the Second Amendment of the NeoGenomics, Inc. 2023 Equity Incentive Plan.” at NeoGenomics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,554,85236,459 00For
BlackRock11,589,0940 00For
First Light Asset Management, LLC9,091,9790 00For
First Trust6,184,2710 00For
Fidelity3,026,9830 00For
Delaware/Macquarie2,787,2050 00For
State Street2,110,8722,495 00For
Aberdeen1,122,0420 00For
Loomis Sayles1,088,3940 00For
Charles Schwab1,068,9980 00For
ALGER FUNDS801,1500 00For
Dimensional688,3070 00For
AMG FUNDS655,5660 00For
JPMorgan468,3520 00For
Equitable291,238100,000 00For
Columbia Threadneedle322,9420 00For
Brighthouse308,7500 00For
TIAA265,3230 00For
Baird262,9180 00For
Harbor Funds II243,6170 00For
Invesco240,6280 00For
DRIEHAUS MUTUAL FUNDS238,2710 00For
Jackson National228,6900 00For
Segall Bryant & Hamill Trust221,4180 00For
QUANTITATIVE MASTER SERIES LLC211,2050 00For

Showing the 25 largest of 77 asset managers. See all 77 in the interactive database.

3. Election of the directors named in the proxy statement as set forth below: Lynn A. Tetrault

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-21.

Combines 3 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 105,727,863AGAINST: 3,367,912

NeoGenomics, Inc.’s own tally for this item (“Elect Director: Lynn A. Tetrault”): 105,727,863 for, 3,367,912 against, per its Form 8-K filed 2026-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 129,653,642 outstanding shares: 82% for, 3% against (84% of the company cast a for/against vote).

The 75 asset managers below cast 97% of the shares they voted on this item FOR (49,587,238 for, 1,553,638 against).

FOR 97%
FOR: 49,587,238 (97.0%)AGAINST: 1,553,638 (3.0%)ABSTAIN: 8 (0.0%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Lynn A. Tetrault” at NeoGenomics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,535,02156,282 80For
BlackRock11,589,0940 00For
First Trust6,184,2710 00For
Fidelity3,026,9830 00For
Delaware/Macquarie2,787,2050 00For
State Street2,110,9912,376 00For
Aberdeen1,122,0420 00For
Loomis Sayles01,088,394 00Against
Charles Schwab1,068,9980 00For
ALGER FUNDS801,1500 00For
Dimensional688,3070 00For
AMG FUNDS655,5660 00For
JPMorgan468,3520 00For
Equitable391,2380 00For
Columbia Threadneedle322,9420 00For
Brighthouse84,477224,273 00Against
TIAA265,3230 00For
Baird262,9180 00For
Harbor Funds II243,6170 00For
Invesco240,6280 00For
DRIEHAUS MUTUAL FUNDS238,2710 00For
Jackson National228,6900 00For
Segall Bryant & Hamill Trust221,4180 00For
QUANTITATIVE MASTER SERIES LLC211,2050 00For
Lincoln Financial188,4790 00For

Showing the 25 largest of 75 asset managers. See all 75 in the interactive database.

4. Election of the directors named in the proxy statement as set forth below: Marjorie C. Green

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-21.

Combines 3 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 109,519,041AGAINST: 778,682

NeoGenomics, Inc.’s own tally for this item (“Elect Director: Dr. Marjorie C. Green”): 109,519,041 for, 778,682 against, per its Form 8-K filed 2026-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 129,653,642 outstanding shares: 84% for, 0.7% against (85% of the company cast a for/against vote).

The 75 asset managers below cast 99.9% of the shares they voted on this item FOR (51,140,879 for, 4 against).

FOR 99.9%
FOR: 51,140,879 (100.0%)AGAINST: 4 (0.0%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Marjorie C. Green” at NeoGenomics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,591,3074 00For
BlackRock11,589,0940 00For
First Trust6,184,2710 00For
Fidelity3,026,9830 00For
Delaware/Macquarie2,787,2050 00For
State Street2,113,3670 00For
Aberdeen1,122,0420 00For
Loomis Sayles1,088,3940 00For
Charles Schwab1,068,9980 00For
ALGER FUNDS801,1500 00For
Dimensional688,3070 00For
AMG FUNDS655,5660 00For
JPMorgan468,3520 00For
Equitable391,2380 00For
Columbia Threadneedle322,9420 00For
Brighthouse308,7500 00For
TIAA265,3230 00For
Baird262,9180 00For
Harbor Funds II243,6170 00For
Invesco240,6280 00For
DRIEHAUS MUTUAL FUNDS238,2710 00For
Jackson National228,6900 00For
Segall Bryant & Hamill Trust221,4180 00For
QUANTITATIVE MASTER SERIES LLC211,2050 00For
Lincoln Financial188,4790 00For

Showing the 25 largest of 75 asset managers. See all 75 in the interactive database.

5. Election of the directors named in the proxy statement as set forth below: Stephen M. Kanovsky

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-21.

Combines 3 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 109,295,532AGAINST: 973,974

NeoGenomics, Inc.’s own tally for this item (“Elect Director: Stephen M. Kanovsky”): 109,295,532 for, 973,974 against, per its Form 8-K filed 2026-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 129,653,642 outstanding shares: 84% for, 0.8% against (85% of the company cast a for/against vote).

The 75 asset managers below cast 99.9% of the shares they voted on this item FOR (51,108,582 for, 32,300 against).

FOR 99.9%
FOR: 51,108,582 (99.9%)AGAINST: 32,300 (0.1%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Stephen M. Kanovsky” at NeoGenomics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,571,49119,819 00For
BlackRock11,589,0940 00For
First Trust6,184,2710 00For
Fidelity3,026,9830 00For
Delaware/Macquarie2,787,2050 00For
State Street2,113,3670 00For
Aberdeen1,122,0420 00For
Loomis Sayles1,088,3940 00For
Charles Schwab1,068,9980 00For
ALGER FUNDS801,1500 00For
Dimensional688,3070 00For
AMG FUNDS655,5660 00For
JPMorgan468,3520 00For
Equitable391,2380 00For
Columbia Threadneedle322,9420 00For
Brighthouse308,7500 00For
TIAA265,3230 00For
Baird262,9180 00For
Harbor Funds II243,6170 00For
Invesco240,6280 00For
DRIEHAUS MUTUAL FUNDS238,2710 00For
Jackson National228,6900 00For
Segall Bryant & Hamill Trust221,4180 00For
QUANTITATIVE MASTER SERIES LLC211,2050 00For
Lincoln Financial188,4790 00For

Showing the 25 largest of 75 asset managers. See all 75 in the interactive database.

6. Election of the directors named in the proxy statement as set forth below: Michael A. Kelly

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-21.

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 104,709,238AGAINST: 5,604,891

NeoGenomics, Inc.’s own tally for this item (“Elect Director: Michael A. Kelly”): 104,709,238 for, 5,604,891 against, per its Form 8-K filed 2026-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 129,653,642 outstanding shares: 81% for, 4% against (85% of the company cast a for/against vote).

The 75 asset managers below cast 96% of the shares they voted on this item FOR (48,864,867 for, 2,276,015 against).

FOR 96%
FOR: 48,864,867 (95.5%)AGAINST: 2,276,015 (4.5%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Michael A. Kelly” at NeoGenomics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,554,82936,481 00For
BlackRock11,589,0940 00For
First Trust6,184,2710 00For
Fidelity3,026,9830 00For
Delaware/Macquarie2,787,2050 00For
State Street2,110,9912,376 00For
Aberdeen1,122,0420 00For
Loomis Sayles01,088,394 00Against
Charles Schwab1,068,9980 00For
ALGER FUNDS801,1500 00For
Dimensional0688,307 00Against
AMG FUNDS655,5660 00For
JPMorgan468,3520 00For
Equitable391,2380 00For
Columbia Threadneedle322,9420 00For
Brighthouse84,477224,273 00Against
TIAA265,3230 00For
Baird262,9180 00For
Harbor Funds II243,6170 00For
Invesco240,6280 00For
DRIEHAUS MUTUAL FUNDS238,2710 00For
Jackson National198,90329,787 00For
Segall Bryant & Hamill Trust221,4180 00For
QUANTITATIVE MASTER SERIES LLC211,2050 00For
Lincoln Financial176,46712,012 00For

Showing the 25 largest of 75 asset managers. See all 75 in the interactive database.

7. Election of the directors named in the proxy statement as set forth below: Felicia Williams

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-21.

Combines 3 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 109,486,148AGAINST: 792,263

NeoGenomics, Inc.’s own tally for this item (“Elect Director: Felicia Williams”): 109,486,148 for, 792,263 against, per its Form 8-K filed 2026-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 129,653,642 outstanding shares: 84% for, 0.7% against (85% of the company cast a for/against vote).

The 75 asset managers below cast 99.9% of the shares they voted on this item FOR (51,130,101 for, 10,782 against).

FOR 99.9%
FOR: 51,130,101 (100.0%)AGAINST: 10,782 (0.0%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Felicia Williams” at NeoGenomics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,591,3074 00For
BlackRock11,589,0940 00For
First Trust6,184,2710 00For
Fidelity3,026,9830 00For
Delaware/Macquarie2,787,2050 00For
State Street2,113,3670 00For
Aberdeen1,122,0420 00For
Loomis Sayles1,088,3940 00For
Charles Schwab1,068,9980 00For
ALGER FUNDS801,1500 00For
Dimensional688,3070 00For
AMG FUNDS655,5660 00For
JPMorgan468,3520 00For
Equitable391,2380 00For
Columbia Threadneedle322,9420 00For
Brighthouse308,7500 00For
TIAA265,3230 00For
Baird262,9180 00For
Harbor Funds II243,6170 00For
Invesco240,6280 00For
DRIEHAUS MUTUAL FUNDS238,2710 00For
Jackson National228,6900 00For
Segall Bryant & Hamill Trust221,4180 00For
QUANTITATIVE MASTER SERIES LLC211,2050 00For
Lincoln Financial188,4790 00For

Showing the 25 largest of 75 asset managers. See all 75 in the interactive database.

8. Election of the directors named in the proxy statement as set forth below: Anthony P. Zook

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-21.

Combines 4 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 109,656,654AGAINST: 657,836

NeoGenomics, Inc.’s own tally for this item (“Elect Director: Anthony P. Zook”): 109,656,654 for, 657,836 against, per its Form 8-K filed 2026-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 129,653,642 outstanding shares: 85% for, 0.6% against (85% of the company cast a for/against vote).

The 75 asset managers below cast 99.9% of the shares they voted on this item FOR (51,140,879 for, 4 against).

FOR 99.9%
FOR: 51,140,879 (100.0%)AGAINST: 4 (0.0%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Anthony P. Zook” at NeoGenomics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,591,3074 00For
BlackRock11,589,0940 00For
First Trust6,184,2710 00For
Fidelity3,026,9830 00For
Delaware/Macquarie2,787,2050 00For
State Street2,113,3670 00For
Aberdeen1,122,0420 00For
Loomis Sayles1,088,3940 00For
Charles Schwab1,068,9980 00For
ALGER FUNDS801,1500 00For
Dimensional688,3070 00For
AMG FUNDS655,5660 00For
JPMorgan468,3520 00For
Equitable391,2380 00For
Columbia Threadneedle322,9420 00For
Brighthouse308,7500 00For
TIAA265,3230 00For
Baird262,9180 00For
Harbor Funds II243,6170 00For
Invesco240,6280 00For
DRIEHAUS MUTUAL FUNDS238,2710 00For
Jackson National228,6900 00For
Segall Bryant & Hamill Trust221,4180 00For
QUANTITATIVE MASTER SERIES LLC211,2050 00For
Lincoln Financial188,4790 00For

Showing the 25 largest of 75 asset managers. See all 75 in the interactive database.

9. RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2026-05-21.

Combines 3 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 116,103,093AGAINST: 494,869

NeoGenomics, Inc.’s own tally for this item (“Proposal 4: The ratification of the appointment of Deloitte & Touche LLP as the independent registered public accountant. The stockholders approved the proposal by the following vote:”): 116,103,093 for, 494,869 against, per its Form 8-K filed 2026-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 129,653,642 outstanding shares: 90% for, 0.4% against (90% of the company cast a for/against vote).

The 75 asset managers below cast 99.8% of the shares they voted on this item FOR (51,082,697 for, 58,186 against).

FOR 99.8%
FOR: 51,082,697 (99.9%)AGAINST: 58,186 (0.1%)
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUN” at NeoGenomics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,591,3092 00For
BlackRock11,589,0940 00For
First Trust6,184,2710 00For
Fidelity3,026,9830 00For
Delaware/Macquarie2,787,2050 00For
State Street2,113,3670 00For
Aberdeen1,122,0420 00For
Loomis Sayles1,088,3940 00For
Charles Schwab1,068,9980 00For
ALGER FUNDS801,1500 00For
Dimensional688,3070 00For
AMG FUNDS655,5660 00For
JPMorgan468,3520 00For
Equitable391,2380 00For
Columbia Threadneedle322,9420 00For
Brighthouse308,7500 00For
TIAA265,3230 00For
Baird262,9180 00For
Harbor Funds II243,6170 00For
Invesco240,6280 00For
DRIEHAUS MUTUAL FUNDS238,2710 00For
Jackson National228,6900 00For
Segall Bryant & Hamill Trust221,4180 00For
QUANTITATIVE MASTER SERIES LLC211,2050 00For
Lincoln Financial188,4790 00For

Showing the 25 largest of 75 asset managers. See all 75 in the interactive database.

10. Election of the directors named in the proxy statement as set forth below: David B. Perez

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-21.

Combines 2 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 106,880,533AGAINST: 3,425,136

NeoGenomics, Inc.’s own tally for this item (“Elect Director: David B. Perez”): 106,880,533 for, 3,425,136 against, per its Form 8-K filed 2026-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 129,653,642 outstanding shares: 82% for, 3% against (85% of the company cast a for/against vote).

The 74 asset managers below cast 97% of the shares they voted on this item FOR (49,616,197 for, 1,521,342 against).

FOR 97%
FOR: 49,616,197 (97.0%)AGAINST: 1,521,342 (3.0%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: David B. Perez” at NeoGenomics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,554,84436,467 00For
BlackRock11,589,0940 00For
First Trust6,184,2710 00For
Fidelity3,026,9830 00For
Delaware/Macquarie2,787,2050 00For
State Street2,110,9912,376 00For
Aberdeen1,122,0420 00For
Loomis Sayles01,088,394 00Against
Charles Schwab1,068,9980 00For
ALGER FUNDS801,1500 00For
Dimensional688,3070 00For
AMG FUNDS655,5660 00For
JPMorgan468,3520 00For
Equitable391,2380 00For
Columbia Threadneedle322,9420 00For
Brighthouse84,477224,273 00Against
TIAA265,3230 00For
Baird262,9180 00For
Harbor Funds II243,6170 00For
Invesco240,6280 00For
DRIEHAUS MUTUAL FUNDS238,2710 00For
Jackson National228,6900 00For
Segall Bryant & Hamill Trust221,4180 00For
QUANTITATIVE MASTER SERIES LLC211,2050 00For
Lincoln Financial188,4790 00For

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

11. Election of the directors named in the proxy statement as set forth below: Dr. Neil Gunn

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-21.

Combines 3 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 107,351,592AGAINST: 2,945,140

NeoGenomics, Inc.’s own tally for this item (“Elect Director: Dr. Neil Gunn”): 107,351,592 for, 2,945,140 against, per its Form 8-K filed 2026-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 129,653,642 outstanding shares: 83% for, 2% against (85% of the company cast a for/against vote).

The 74 asset managers below cast 97% of the shares they voted on this item FOR (49,644,936 for, 1,492,603 against).

FOR 97%
FOR: 49,644,936 (97.1%)AGAINST: 1,492,603 (2.9%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Dr. Neil Gunn” at NeoGenomics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,591,29516 00For
BlackRock11,589,0940 00For
First Trust6,184,2710 00For
Fidelity3,026,9830 00For
Delaware/Macquarie2,787,2050 00For
State Street2,113,3670 00For
Aberdeen1,122,0420 00For
Loomis Sayles01,088,394 00Against
Charles Schwab1,068,9980 00For
ALGER FUNDS801,1500 00For
Dimensional688,3070 00For
AMG FUNDS655,5660 00For
JPMorgan468,3520 00For
Equitable391,2380 00For
Columbia Threadneedle322,9420 00For
Brighthouse84,477224,273 00Against
TIAA265,3230 00For
Baird262,9180 00For
Harbor Funds II243,6170 00For
Invesco240,6280 00For
DRIEHAUS MUTUAL FUNDS238,2710 00For
Jackson National228,6900 00For
Segall Bryant & Hamill Trust221,4180 00For
QUANTITATIVE MASTER SERIES LLC211,2050 00For
Lincoln Financial188,4790 00For

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

12. Election of the directors named in the proxy statement as set forth below: John P. Kenny

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-21.

Combines 3 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 110,028,235AGAINST: 268,748

NeoGenomics, Inc.’s own tally for this item (“Elect Director: John P. Kenny”): 110,028,235 for, 268,748 against, per its Form 8-K filed 2026-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 129,653,642 outstanding shares: 85% for, 0.3% against (85% of the company cast a for/against vote).

The 74 asset managers below cast 99.9% of the shares they voted on this item FOR (51,137,538 for, 1 against).

FOR 99.9%
FOR: 51,137,538 (100.0%)AGAINST: 1 (0.0%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: John P. Kenny” at NeoGenomics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,591,3101 00For
BlackRock11,589,0940 00For
First Trust6,184,2710 00For
Fidelity3,026,9830 00For
Delaware/Macquarie2,787,2050 00For
State Street2,113,3670 00For
Aberdeen1,122,0420 00For
Loomis Sayles1,088,3940 00For
Charles Schwab1,068,9980 00For
ALGER FUNDS801,1500 00For
Dimensional688,3070 00For
AMG FUNDS655,5660 00For
JPMorgan468,3520 00For
Equitable391,2380 00For
Columbia Threadneedle322,9420 00For
Brighthouse308,7500 00For
TIAA265,3230 00For
Baird262,9180 00For
Harbor Funds II243,6170 00For
Invesco240,6280 00For
DRIEHAUS MUTUAL FUNDS238,2710 00For
Jackson National228,6900 00For
Segall Bryant & Hamill Trust221,4180 00For
QUANTITATIVE MASTER SERIES LLC211,2050 00For
Lincoln Financial188,4790 00For

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

13. Amend Omnibus Stock Plan

COMPENSATION

Meeting held 2026-05-21.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (101,059 for, 0 against).

FOR: 101,059 (100.0%)
Largest asset managers voting on “Amend Omnibus Stock Plan” at NeoGenomics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Empower94,6590 00For
CLEARWATER INVESTMENT TRUST6,4000 00For

14. Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-05-22 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).

82% Majority: yes · of votes cast

FOR 82%AGAINST 18%
FOR: 87,823,189AGAINST: 19,573,234

NeoGenomics, Inc.’s own tally for this item (“Proposal 2: The approval, on an advisory basis, of the compensation paid to the Company's Named Executive Officers, as identified in the proxy statement for the Annual Meeting. The advisory approval received an affirmati”): 87,823,189 for, 19,573,234 against, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 129,653,642 outstanding shares: 68% for, 15% against (83% of the company cast a for/against vote).

The 2 asset managers below cast 100% of the shares they voted on this item FOR (1,028,167 for, 0 against).

FOR 100%
FOR: 1,028,167 (100.0%)
Largest asset managers voting on “Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers.” at NeoGenomics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
GLENMEDE FUND INC1,002,1670 00For
FIRST UNITED BANK & TRUST26,0000 00For

15. Recommend, on a non-binding advisory basis, the Frequency of Future Advisory Votes on Executive Compensation.

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-05-22 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).

— fund support · no official result

ONE YEAR 97%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

ONE YEAR: 1,002,167 (97.5%)1 YEAR: 26,000 (2.5%)
Largest asset managers voting on “Recommend, on a non-binding advisory basis, the Frequency of Future Advisory Votes on Executive Compensation.” at NeoGenomics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
GLENMEDE FUND INC00 00One Year
FIRST UNITED BANK & TRUST00 001 Year

Largest NeoGenomics, Inc. shareholders voting in 2025-2026

Ranked by the number of NeoGenomics, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 129,653,642 shares outstanding at the time of that meeting.

Top NeoGenomics, Inc. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1BlackRock 12.43%
2Vanguard 11.26%
3First Light Asset Management, LLC 7.01%
4Greenhouse Funds LLLP 5.77%
5First Trust 4.80%
6State Street 3.55%
7GEODE CAPITAL MANAGEMENT, LLC 2.48%
8Fidelity 2.46%
9NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST 2.44%
10Aberdeen 2.43%

Reported NeoGenomics, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

NeoGenomics, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
BlackRock 15.39% 13F
Vanguard Group 10.67% 13F
First Light Asset Management, LLC 7.36% DEF14A
Brown Advisory Incorporated 7.36% DEF14A
Greenhouse Funds LLLP 7.11% 13G
Vanguard Portfolio Management 5.92% 13G
State Street 3.95% 13F
D.E. Shaw 3.21% 13F
Dimensional Fund Advisors 2.06% 13F
Millennium Management 1.71% 13F

Percentages above are of 129,653,642 shares outstanding, as reported by NeoGenomics, Inc. on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from NeoGenomics, Inc.’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At NeoGenomics, Inc.'s shareholder meeting held 2026-05-21, in the 2025-2026 proxy season, 288 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,488 separate fund positions. Their filings are grouped here into 15 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named… — FOR was 83% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: NeoGenomics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-05-22.

NeoGenomics, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).